A
$ Value
$0
Shares
10,046
Price
$0
Filed
Oct 14
Insider
Name
Hahn Mark W
Title
—
CIK
0001408502
Roles
Director
Transaction Details
Transaction Date
2025-10-13
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
10,046
Footnotes
These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. One-third of the RSUs shall vest on October 13, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date.
Filing Info
Hahn Mark W's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-10-13 | SLNO | A | $0 |
| 2025-10-07 | VRNA | D | — |
| 2025-10-07 | VRNA | M | — |
| 2025-10-07 | VRNA | D | — |
| 2025-10-07 | VRNA | M | — |
| 2025-10-07 | VRNA | M | — |
| 2025-10-07 | VRNA | M | — |
| 2025-10-07 | VRNA | A | — |
| 2025-10-07 | VRNA | M | — |
| 2025-08-29 | VRNA | G | $0 |
Other Insiders at SLNO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Manning Meredith
Chief Commercial Officer
|
— | $229K | 2026-03-27 |
|
Huang Michael F.
Sr. VP of Clinical Development
|
— | $200K | 2026-03-27 |